Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | BMC Cancer

Fig. 5

From: Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy

Fig. 5

Tumor-specific CTLs. Mice in various groups were injected with 5 × 105 CT26 tumor cells subcutaneously on day zero and with mEHT on day 14, before being given DC injection on day 15. On day 30 following tumor injection, splenocytes were harvested for CTL assay. Cytotoxic activity of splenocytes was determined by LDH-release assay at various effector/target cells (E/T) ratios

Back to article page